Key learnings from the INBUILD trial in patients with progressive pulmonary fibrosis
In a patient with interstitial lung disease (ILD) of known or unknown etiology other than idiopathic pulmonary fibrosis (IPF), progressive pulmonary fibrosis (PPF) is defined by worsening lung fibrosis on high-resolution computed tomography (HRCT), decline in lung function, and/or deterioration in s...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2024-08-01
|
| Col·lecció: | Therapeutic Advances in Respiratory Disease |
| Accés en línia: | https://doi.org/10.1177/17534666241266343 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|